in past times number of years, the united kingdom has witnessed a revolution in clinical weight‑decline remedies — from the introduction of semaglutide (Wegovy®) towards the growing popularity of tirzepatide (Mounjaro®). Now, another name is drawing consideration in both clinical and public welln